Pulse first to offer Reframe Cancer’s combined screening and navigation product

Pulse Insurance has become the first UK insurer to offer a combined cancer screening and navigation product from Reframe Cancer, offering access to the company’s screening product for group and individual customers.

Policyholders will also have access to Reframe Cancer’s information hub and resource library.

The move follows the August 2024 launch of Reframe Cancer’s navigation-led cancer care product in partnership with Pulse and Rokstone, the international speciality (re)insurance MGA within Aventum Group. Pulse says it sees the product as an alternative to critical illness insurance for individuals who have not had cancer but have a history of health issues such as diabetes or heart problems.

The product includes a lump-sum payment on first diagnosis for 95% of cancers, a personalised care plan, support from a dedicated cancer nurse and cancer support manager, and pre-diagnosis guidance.

Mark Stephenson, chief executive of Reframe Cancer (pictured) said: ‘This is another groundbreaking move by Pulse. Their forward thinking approach to cancer navigation and prevention builds on the launch of the cancer care product from last year. Being able to now offer both group and individual policy holders cancer screening thanks to Reframe’s CQC regulated product feels like a natural enhancement; I am delighted that they are the first insurance provider to market with our combined screening and cancer navigation insurance product. It is testament to the ethos and vision of Pulse that employees will also receive access to Reframe’s screening product and expert advice and guidance.’

Ben Broom, head of health at Pulse Insurance, said: ‘This is another exciting step forward for Pulse. We believe that the combination of our specialist insurance expertise coupled with Reframe Cancer’s unique support and resources will enable groups and individuals to benefit not just from help if they are diagnosed with cancer but also to have easy access to screening right now – we know that cancer diagnosed at an early stage, is more likely to be treated successfully. Spotting cancer early really does save lives.’